Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors
====================================================================================================================================================

* Yu-Chao Zhu
* Hany M Elsheikha
* Jian-Hua Wang
* Shuai Fang
* Jun-Jun He
* Xing-Quan Zhu
* Jia Chen